Countries affected
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData's latest Coronavirus Influencers…
Here are the latest figures on the spread of the Covid-19 virus, updated in real time.
Both cases of the virus and associated deaths have risen sharply since the first cases emerged in China at the end of 2019..
You can use our interactive to explore the number of cases and deaths in different countries across the world since the start of the outbreak.
While many countries have hit hard by Covid-19, the number of deaths is following a different trajectory in each.
Cities – with their densely-packed, highly mobile populations – are responsible for a disproportionately high number of cases across the world.
Cities – with their high population density, young and mobile demographics, and developed public transport systems – are particularly susceptible to rapidly-spreading viral outbreak. Here we drill down into subnational Covid-19 figures to show which areas are seeing disproportionate numbers of Covid-19 cases. While different countries count at different administrative levels, the pattern is clear: London and Madrid are “regions” in their own right, while New York State includes New York City, Ile-de-France covers Paris, and Lombardy covers Milan. This chart is currently being updated weekly with the latest figures – although some countries have a slight delay in publishing the very latest case numbers by region or state.
We are using the power of GlobalData’s huge network of economic analysts to start to track the impact of Covid-19 on different world regions and economic sectors. New charts will be added here in coming days and weeks, and constantly updated with the latest intelligence.
We are using exclusive dynamic figures provided by GlobalData analysts to track key economic indicators in major world economies hit by Covid-19. Deaths from the virus are plotted alongside the indexed performance of each country’s major stock exchange and the number of “active jobs” – jobs open for applications across all major industries. Figures are tracked daily from the March 1, 2020.
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData's latest Coronavirus Influencers…
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the updates…
Coronavirus Influencers Pharmaceutical companies are in the spotlight as they race to develop treatments for…
Answers to some of the most popular FAQs on coronavirus outbreak and COVID-19
Vir Biotechnology and GlaxoSmithKline (GSK) have reported that an independent Data and Safety Monitoring Board (DSMB) has recommended halting enrolment in the VIR-7831 (GSK4182136) arm…
ObvioHealth is set to initiate a Phase II/III study of RedHill Biopharma’s RHB-107 (upamostat) in the US for Covid-19 treatment. ObvioHealth will use its clinical…
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as…
Veru is all set to advance its drug, VERU-111, into a Phase III registration clinical study in hospitalised high-risk Covid-19 patients on obtaining clinically meaningful…
Partner Therapeutics has reported positive top-line results from the investigator-led study of inhaled Leukine (sargramostim) in hospitalised Covid-19 patients. A yeast-derived recombinant human granulocyte-macrophage colony…
Atossa Therapeutics has reported positive final results from the Phase I clinical study of AT-301 nasal spray being developed to reduce Covid-19 symptoms in patients…